Skip to content
Screener

First Tracks Biotherapeutics Inc TRAX Total Liabilities & Equity

Total Liabilities & Equity at other companies

BK
BKBK
$561.52B+27.4%
Schering-Plough logo
Schering-PloughSGP
$258.39M
GPA
General Purpose Acquisition Corp.GPAC
$9.44M-17.6%
Veradermics logo
VeradermicsMANE
$397.36M
Polaryx Therapeutics, Inc. logo
Polaryx Therapeutics, Inc.PLYX
$3.5M
Dollar General logo
Dollar GeneralDG
$31.7B+2.3%

Where this comes from

Reported directly by First Tracks Biotherapeutics Inc in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The source filing: First Tracks Biotherapeutics Inc’s 10-Q, filed May 14, 2026.

Filed
May 14, 2026, 4:32 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-224190
Line itemMarch 31, 2026December 31,2025
Current portion of operating lease liability2,080
Total current liabilities33,11231,023
Operating lease liability, net of current portion12,032
Equity:
Net Parent Investment257,610287,514
Accumulated other comprehensive loss(146)(24)
Total equity257,464287,490
Total liabilities and equity$290,576$330,545

Item 1. Combined Financial Statements.

FAQ

What is First Tracks Biotherapeutics Inc's total liabilities & equity?
First Tracks Biotherapeutics Inc (TRAX) reported total liabilities & equity of $290.58M in Q1 2026.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.

Ask your AI about First Tracks Biotherapeutics Inc's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude